Related Experiment Video
Updated: Aug 11, 2026
Multi-exon Skipping Using Cocktail Antisense Oligonucleotides in the Canine X-linked Muscular Dystrophy
Published on: May 24, 2016
Duchenne muscular dystrophy gene product is not identical in muscle and brain
1Department of Cell Biology, Weizmann Institute of Science, Rehovot, Israel.
Abstract:
Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder resulting in progressive degeneration of the muscle. It affects about 1 in 3,500 male children. Becker's muscular dystrophy is a less severe disease allelic to DMD. Some 30% of DMD patients suffer from various degrees of mental retardation. The giant DMD gene spans about 2,000 kilobases and codes for a 14-kilobase messenger RNA and a protein of molecular weight 427,000. DMD mRNA is most abundant in skeletal and cardiac muscle and less so in smooth muscle. We reported that the expression of the gene is developmentally regulated during the differentiation of primary muscle cultures and in myogenic cell lines in a way similar to the expression of muscle-specific genes such as myosin light chain 2 and skeletal muscle actin. Similar results have been obtained with human primary myogenic cells. Significant levels of DMD mRNA are found in brain tissue. Here we show that the transcript of the DMD gene and the amino terminal of the encoded protein differ in brain and muscle. The 5' ends of these mRNA species are derived from different exons. The results suggest that the two mRNA types are transcribed from different promoters.
Insights
Duchenne muscular dystrophy (DMD) gene expression differs between brain and muscle tissues. This study reveals distinct DMD transcripts and protein N-termini, suggesting different promoters regulate brain and muscle gene activity.
Area of Science:
- Molecular Biology
- Genetics
- Neuroscience
Background:
- Duchenne muscular dystrophy (DMD) is a severe X-linked muscle degeneration disorder affecting 1 in 3,500 males.
- DMD patients may exhibit mental retardation, indicating potential neurological involvement.
- The DMD gene is large, encoding a massive protein crucial for muscle function.
Purpose of the Study:
- To investigate the expression and characteristics of the DMD gene in brain tissue.
- To determine if DMD gene transcripts and protein products differ between brain and muscle.
- To explore the regulatory mechanisms of DMD gene expression in different tissues.
Main Methods:
- Analysis of DMD gene mRNA abundance in various tissues, including brain and muscle.
- Characterization of DMD mRNA 5' ends using molecular techniques.
- Comparison of DMD protein N-terminal sequences derived from brain and muscle transcripts.
Main Results:
- Significant levels of DMD mRNA were detected in brain tissue, alongside muscle.
- DMD transcripts in the brain exhibit different 5' ends compared to muscle.
- The amino-terminal regions of DMD proteins encoded by brain and muscle transcripts are distinct.
Conclusions:
- The DMD gene produces different mRNA species in the brain and muscle.
- These distinct transcripts likely originate from different promoters, indicating tissue-specific gene regulation.
- This differential expression may contribute to the neurological aspects observed in some DMD patients.
Related Concept Videos
01:37Neural Regulation
01:43Sex-linked Disorders
01:21Satellite Stem Cells and Muscular Dystrophy
01:28Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
01:21Huntington Disease l: Introduction